Banerjee Subhashis
Chief Medical Officer
Banerjee Subhashis has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Banerjee Subhashis is listed as Chief Medical Officer at Artiva Biotherapeutics, Inc. Inside the rolling window, Banerjee Subhashis reported no open-market purchases and 5 open-market sales totaling $187K in ARTV. The largest disclosed transaction in the window is a sale of 8,222 ARTV shares on Aug 27, 2026, worth $99K.
Companies traded
Other insiders at ARTV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$187K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Banerjee Subhashis made?
Banerjee Subhashis has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Banerjee Subhashis trade?
Banerjee Subhashis has filed SEC Form 4 disclosures for 1 company, including ARTV.
When was Banerjee Subhashis's most recent SEC Form 4 filing?
Banerjee Subhashis's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Banerjee Subhashis's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Banerjee Subhashis is listed as Chief Medical Officer.
What is Banerjee Subhashis's total buy and sell value in the current window?
Inside the rolling retention window, Banerjee Subhashis bought $0 and sold $187K based on SEC Form 4 filings.
What was Banerjee Subhashis's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,222 ARTV shares on 2026-08-27, worth $99K, per SEC Form 4 filings.